Calidi Biotherapeutics, Inc. (NYSE:CLDI) appears in 29 institutional 13F filings for the quarter ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 879,000 | 879,000 | 0.00% | $209,905.00 |
| SABBY MANAGEMENT, LLC | 31 Mar, 2026 | 434,903 | 434,903 | 0.00% | $103,855.00 |
| Warberg Asset Management LLC | 31 Mar, 2026 | 250,000 | 250,000 | 0.00% | $59,475.00 |
| HighTower Advisors, LLC | 31 Mar, 2026 | 83,523 | 0 | 0.00% | $19,945.00 |
| Virtu Financial LLC | 31 Mar, 2026 | 75,769 | 54,526 | 256.68% | $18.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 63,019 | 21,090 | 50.30% | $15,048.00 |
| RS CRUM INC. | 31 Mar, 2026 | 40,256 | 20,000 | 98.74% | $9,614.00 |
| Arax Advisory Partners | 31 Mar, 2026 | 37,345 | 37,345 | 0.00% | $8,918.00 |
| JANE STREET GROUP, LLC | 31 Mar, 2026 | 34,802 | 23,311 | 202.86% | $8,311.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 25,509 | 25,509 | 0.00% | $6,097.00 |
| Belpointe Asset Management LLC | 31 Mar, 2026 | 19,921 | -50 | -0.25% | $4,757.00 |
| Northern Trust Corp | 31 Mar, 2026 | 17,758 | 0 | 0.00% | $4,241.00 |
| HRT FINANCIAL LP | 31 Mar, 2026 | 10,133 | 10,133 | 0.00% | $2.00 |
| Farther Finance Advisors, LLC | 31 Mar, 2026 | 10,000 | 0 | 0.00% | $2,426.00 |
| Morgan Stanley | 31 Mar, 2026 | 9,467 | 8,000 | 545.33% | $2,261.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 9,219 | 9,219 | 0.00% | $2,203.00 |
| OSAIC HOLDINGS, INC. | 31 Mar, 2026 | 2,106 | 0 | 0.00% | $503.00 |
| Tower Research Capital LLC (TRC) | 31 Mar, 2026 | 1,396 | -1,378 | -49.68% | $333.00 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,042 | 0 | 0.00% | $248.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 1,042 | 1,042 | 0.00% | $248.00 |